2011-3-A-1130 What Are the New Sepsis Biomarkers – Mike Winters
Tags
2011-3-A-1130 What Are the New Sepsis Biomarkers – Mike Winters
2011-3-A-0900 What Does CORTICUS Tell Us in Steroids and Sepsis – Mike Winters
2011-3-A-0830 Does Pressor Choice or Use in Sepsis Change Outcomes – Evie Marcolini
2011-3-A-0800 Does Antibotic Choice in Sepsis Change Outcomes – Evie Marcolini
3-E-1100 The I.S.S.S. Study (International Score of Shock Severity) – Ana Maria Navio Serrano (Spain)
2-B-1430 Identification of Sepsis – Is It Possible in the Prehospital Setting – Maaret Castren (Sweden)
1-A-1730 Full or Empty – Diagnostic Challenges for the Patient in Shock – Fernando Schiraldi (Italy)
1-A-1700 Lactate in ED Shock – What Does It Mean and How Do I Use It – Alan Jones (Mississippi)
1-A-1630 Biomarkers in Sepsis – Are They Useful – Abdel Bellou (France)
1-A-1530 The Importance of the Autonomic Nervous System in Early Sepsis – Christoph Dodt (Germany)
1-A-1500 Procalcitonin – How Useful Is It in the ED – David A. Talan (California)
1-A-1430 Non-Invasive Tools for Diagnosis-Monitoring of Shock-Sepsis in the ED – Vu Kiet Tran (Canada)
2011-1-C-1700 Sickle Cell Child in Shock – Elizabeth Weinstein
2011-09-01-0800 68-year-old woman found on the floor – Dan del Portal (CC)
2011-04-29 1235 Modulation of the moradrenergic system – a future of sepsis management – Djillali Annane